ORBIMED ADVISORS LLC X4 Pharmaceuticals, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$8.59M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+77.20%
quarter

X4 Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +265.89% 3.65M shares 7.27M $1.71 5.02M
Q2 2022 share 0.00% 0 shares -1.07M $0.97 1.37M
Q1 2022 share 0.00% 0 shares -742K $1.75 1.37M
Q4 2021 share 0.00% 0 shares -4.12M $2.27 1.37M
Q3 2021 share 0.00% 0 shares -1.66M $5.29 1.37M
Q2 2021 share 0.00% 0 shares -2.89M $6.5 1.37M
Q1 2021 share Increase +26.45% 287.35K shares 4.84M $8.61 1.37M
Q4 2020 share 0.00% 0 shares -370K $6.43 1.08M
Q3 2020 share 0.00% 0 shares -2.77M $6.77 1.08M
Q2 2020 share 0.00% 0 shares -739K $9.32 1.08M
Q1 2020 share 0.00% 0 shares -760K $10 1.08M
Q4 2019 share Increase +16.02% 150K shares -278K $10.7 1.08M
Q3 2019 share 0.00% 0 shares -2.14M $12.71 936.49K
Q2 2019 share Increase +200.65% 625K shares 8.62M $15 936.49K
Q1 2019 share Increase 0.00% 311.49K shares 5.42M $17.41 311.49K